250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotechnology VC (Venture Capital) Funds in France in October 2024

A list of 50 VC (Venture Capital) funds that invest in Biotechnology startups based in France. We rank investors based on the number of investments they made in Biotechnology companies from France. We update this investor list every month.

Top 50 Biotechnology VC (Venture Capital) Funds in France in October 2024

Investor Biotechnology France investments
Bpifrance 49
GO CAPITAL 26
Kurma Partners 25
Karista 25
Seventure Partners 22
Sofinnova Partners 21
Auriga Partners 19
Elaia 17
Idinvest Partners 16
Omnes Capital 15
Sofimac Investment Managers 12
AQUITI Gestion 11
AdBio partners 11
Inserm Transfert Initiative 9
Cap Innov'Est 9
Galia Gestion 8
Pontifax 7
Sham Innovation Santé 7
Meusinvest (Noshaq) 7
Crédit Agricole 7
M Capital Partners 6
Caisse d’Epargne 6
BNP Paribas 6
WiSEED 6
SOSV 6
IRDI 6
Angels Santé 6
Normandie Participations 6
Paca Investissement 6
IRDI SORIDEC Gestion 5
Crédit Mutuel Innovation 5
CEA Investissement 5
UI Investissement 5
Starquest Capital 5
Octalfa 5
BNP Paribas Développement 5
Truffle Capital 4
Heartcore Capital 4
Supernova Invest 4
Emertec 4
IXO Private Equity 4
ACG Management 4
Demeter 4
AgFunder 4
M Ventures 4
XAnge 4
KREAXI 4
Finovam Gestion 4
Aurinvest 4
Casdin Capital 4
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Bpifrance VC Fund · Maisons-alfort, Ile-de-France, France · 80 investments in the past 12 months
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • France, United States, Switzerland
Portfolio highlights
  • Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
  • Oderis — Oderis helps corporate and private equity clients with transaction advisory, business valuation, consulting and financial assistance.
  • VELA — VELA is an innovative 100% wind-powered maritime transport. It has been working to address the climate emergency by providing a creative, sustainable, and socially responsible maritime transportation solution.
GO CAPITAL VC Fund · Rennes, Bretagne, France · 7 investments in the past 12 months
GO CAPITAL is a management company approved by the AMF and a member of AFIC. It is based in Rennes, and manages more than 130 million of assets by investing primarily in western France in innovative companies with high growth potential.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Seed, Series A
  • France, Canada, Israel
Portfolio highlights
  • BIOPHTA — BIOPHTA has pioneered a new approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery. Their non-invasive topical ocular inserts represent a significant advancement in the treatment of many ophthalmic disorders, providing superior long-term disease management.
  • Brightflow — Brightflow operates as a medical device startup.
  • Dealt — Dealt - La solution servicielle qui transforme votre activité retail et e-commerce
Montage, installation, configuration, entretien ou réparation… Dealt construit, implémente et gère votre offre de services en marque blanche, pour vous permettre de mieux accompagner vos clients et vous démarquer de la concurrence.Pour cela, Dealt met àdisposition des distributeurs une solution omnicanale complète, comprenant : - Les outils technologiques pour implémenter leur offre de services en marque blanche : plateforme de services, API, solution vendeur et back-office - Un catalogue de +300 services à tarifs négociés - Une communauté nationale de 10 000 professionnels certifiés - Un accompagnement total pour développer leur stratégie serviciellePassez d’un modèle de vendeur de produits à vendeur de solutions avec Dealt !Pourquoi adopter Dealt ? * +300 services disponibles * +10 000 Experts professionnels certifiés * +40 000 prestations réalisées * 4,86/5 de note moyenne * 94% de couverture nationaleCes enseignes nous font confiance : E.Leclerc, Mr. Bricolage, Botanic, Conforama, Monoprix, Casino, La Poste, Carmila…Dealt récompensé par l’écosystème retail français :- Lauréat des Trophées de l’Innovation E.Leclerc 2021, catégorie « Innovation Expérientielle »- Lauréat des Trophées 100% Retailtech LSA 2021, catégorie « Digitalisation du point de vente, expérience client et solution de paiement » - Elu start-up de l’année 2021 lors de l’événement « Connect Lille »Dealt est soutenu par le Groupe La Poste
Kurma Partners VC Fund · Paris, Ile-de-France, France · 7 investments in the past 12 months
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more
Investment focus
  • Health Care, Biotechnology, Pharmaceutical
  • Series A, Series B, Seed
  • France, Switzerland, Spain
Portfolio highlights
  • SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
  • PanTera — PanTera wants to bring a new hope to cancer patients by enabling the widespread use of radiopharmaceuticals for personalised treatment of tumors
  • Spotlight Medical — Spotlight Medical is a precision medicine company striving to free all patients from cancer through a better understanding of each patient’s unique disease. We develop advanced AI tests that enhance treatment selection by leveraging decades of patient data. This ensures personalized and effective care for each individual, significantly improvingpatient outcomes and quality of life. By closely collaborating with physicians, we create impactful tests that address critical unmet clinical needs, opening a new era in cancer care.
Karista VC Fund · Paris, Ile-de-France, France · 5 investments in the past 12 months
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Seed, Series A, Series B
  • France, United States, Germany
Portfolio highlights
  • 10Lines — 10Lines is developing autonomous parking lot marking robots and technological solutions to significantly increase productivity in the industry of pavement marking. Our solutions are helping striping businesses do their work much more productively with a smaller environmental footprint.
  • BforeAI — Starting from patented technology developed in years of research, BforeAi is the prediction service that looks for newly registered or morphed domains, and score their maliciousness looking at metadata and links to other bad guys.
  • Brightflow — Brightflow operates as a medical device startup.
Seventure Partners VC Fund · Paris, Ile-de-France, France · 6 investments in the past 12 months
Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series A, Series B, Funding Round
  • France, United States, Germany
Portfolio highlights
  • ID5 — ID5 provides a comprehensive suite of identification services designed to improve to improve addressability and measurement across all environments
  • Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
  • Sequentia Biotech — Sequentia Biotech is a bioinformatics company that offers services for healthcare, pharma, agriculture, industry and environment.
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 21 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • deepc — The Radiology AI Platform - Your effortless access to AI
  • Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
  • Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
Auriga Partners VC Fund · Paris, Ile-de-France, France
Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • France, United States, Switzerland
Portfolio highlights
  • Patrowl — Identify and harden your External Security Posture with the leader. Let us manage time-consuming tasks and focus on remediation
  • Exeliom — Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.
  • Vade Secure — Vade is a global leader in predictive email defense, protecting 1 billion inboxes worldwide. AI-based email security for Microsoft 365.
Elaia VC Fund · Paris, Ile-de-France, France · 22 investments in the past 12 months
Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Series B
  • France, United States, Spain
Portfolio highlights
  • Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
  • SURGAR — SURGAR provides a plug-and-play augmented reality software suite for computer-aided laparoscopic surgery.
  • Continuity — Continuity’s SaaS platform uses Open Data and AI to detect insurance contracts that are either outdated or invalid across four product lines including Professional Indemnity, Commercial Property, Construction Workers Insurance, and Directors & Officers Liability.
Idinvest Partners VC Fund · Paris, Ile-de-France, France
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series B, Series A, Funding Round
  • France, United States, Spain
Portfolio highlights
  • Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability
Omnes Capital VC Fund · Paris, Ile-de-France, France · 5 investments in the past 12 months
Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Series A, Funding Round, Series B
  • France, Germany, United States
Portfolio highlights
  • Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
  • Carbyon — Carbyon is a Netherlands-based company that develops direct air capture (DAC) technologies. The company's fuels help to replace fossil hydrocarbons with electrical batteries or hydrogen (H2), alternative energy carriers that are used to store renewable electricity and make major changes to transportation facilities, energy grids, and gastransportation networks, filters CO2 from the air and supply it in a purified form to make kerosene for aircraft, enabling existing fossil industry to re-use and repurpose these storage and transport facilities for renewable hydrocarbons.
  • Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.
Sofimac Investment Managers VC Fund · Clermont-ferrand, Auvergne, France
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Show more
Investment focus
  • Biotechnology, Health Care, Manufacturing
  • Funding Round, Seed, Series A
  • France, Italy, Austria
Portfolio highlights
  • Blue Valet — Blue Valet is a provider of valet parking-parking at airports and train stations.
  • Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
  • Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
AQUITI Gestion VC Fund · Bordeaux, Aquitaine, France · 3 investments in the past 12 months
Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Series A, Seed
  • France, United States
Portfolio highlights
  • Dionymer — dionymer creates endless opportunities for a multitude of industries. Replacing petrochemical polymers with a circular and biodegradable alternative.
  • Materrup — Materrup produces low-carbon earth concrete for construction and urban development. Materrup construction solutions meet the requirements of future RE2020 regulations and the urgent need to reduce the carbon footprint of the construction industry.
  • ALOGIA Groupe — ALOGIA Groupe offers preventive health responses to senior people at home through care management and innovative services.
AdBio partners VC Fund · Paris, Ile-de-France, France
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Seed, Series A, Funding Round
  • France, Spain, Belgium
Portfolio highlights
  • Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases
Inserm Transfert Initiative VC Fund · Paris, Ile-de-France, France
Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Series A, Series B, Seed
  • France, Switzerland, United States
Portfolio highlights
  • Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
  • VectivBio — We Are Ironwood
  • Aelis Farma — Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways.Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.
Cap Innov'Est VC Fund · Illkirch-graffenstaden, Alsace, France
Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC
Show more
Investment focus
  • Biotechnology, Pharmaceutical, Health Care
  • Seed, Series A, Funding Round
  • France, United States
Portfolio highlights
  • VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
  • Opencell Software — Increase recurring revenue. Opencell's platform simplifies launch, scales with your business, and streamlines billing. Optimize sales cycles, improve customer experience, and gain valuable revenue insights. Start today!
  • Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.
Galia Gestion VC Fund · Bordeaux, Aquitaine, France
Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.
Show more
Investment focus
  • Software, Manufacturing, Biotechnology
  • Funding Round, Series A, Seed
  • France, United States
Portfolio highlights
  • Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
  • Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Pontifax VC Fund · Herzliya, Tel Aviv, Israel
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Israel, France
Portfolio highlights
  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
  • AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
Sham Innovation Santé VC Fund · Lyon, Rhone-Alpes, France
Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.
Show more
Investment focus
  • Biotechnology, Medical Device, Medical
  • Series B, Series A, Funding Round
  • France
Portfolio highlights
  • Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
  • Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Meusinvest (Noshaq) VC Fund · Liège, Liege, Belgium · 10 investments in the past 12 months
Noshaq offers financial services to help businesses develop.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Funding Round
  • Belgium, France, Germany
Portfolio highlights
  • Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
  • Get Your Way — Discover the future of assisted reality with Get Your Way's aRdent smart glasses. Perfect for SMEs looking for innovative solutions to improve their business
  • Brenus Pharma — Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.
Crédit Agricole VC Fund · Paris, Ile-de-France, France · 5 investments in the past 12 months
Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.
Show more
Investment focus
  • Software, Manufacturing, Health Care
  • Funding Round, Seed, Debt Financing
  • France, United States, Italy
Portfolio highlights
  • Quai des Notaires — Vente, succession, signez l'esprit tranquille. Sans rdv et gratuit ! Trouvez votre notaire en ligne.
  • Technique Solaire — Technique Solaire specializes in the distribution of photovoltaic energy for individuals and businesses as corant from solar panels.
  • Arkeon Energy Systems — Arkeon Energy Systems develops hermodynamic cycles and thermal stages to meet heating, air conditioning, and electricity needs.
M Capital Partners VC Fund · Toulouse, Midi-Pyrenees, France · 3 investments in the past 12 months
M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.
Show more
Investment focus
  • Health Care, Software, Food and Beverage
  • Funding Round, Seed, Series A
  • France, United States, Canada
Portfolio highlights
  • Fasst — Fasst is involved in the creation, distribution, consulting, and connection of unique digital insurance solutions for brokers and insurers.
  • Hakbah — Hakbah is a Fintech startup focusing on an alternative financial saving. Hakbah is modernizing financial saving via its intelligent platform by offering a comprehensive one-stop-shop solution for Savings Groups to initiate, manage, join, and pay directly within the mobile app.
  • Demether — Demether is a DeFi protocol that works to enable zero-cost access to TVL for blockchains.
Caisse d’Epargne VC Fund · Paris, Ile-de-France, France · 5 investments in the past 12 months
Caisse d’Epargne is a cooperative bank that supports all economic players. It shares its values ​​of social responsibility and humanism with its member customers. It is committed to the heart of the regions, the 15 regional savings banks are involved on a daily basis in their clients' projects and provide them with tailor-made solutions.Ithas now had 4.8 million members and 20.6 million customers, managed by 4,182 bank branches and the My Online Banker branch.It was created in 1818 and is headquartered in Paris, France.
Show more
Investment focus
  • Health Care, Biotechnology, Manufacturing
  • Funding Round, Debt Financing, Seed
  • France
Portfolio highlights
  • Scalingo — Discover Scalingo the 1st European PaaS certified HDS (Health Data Hosting) and ISO 27001. Host your app in France and enjoy top-notch client support. Deploy your apps faster.
  • Jared — Jared is an early-stage fintech company that has developed the first intelligent financial assistant for the B2C Market that addresses the need for daily support in understanding and anticipating each individual’s financial needs and objectives.Managing finances is everyone's business, regardless of the amount of their incomes or wealth.Jared comes up to balance deep inequalities in our finances due to differences in financial education. Even if many support and advice solutions do exist (financial advisors, bank advisors, Agregators & Asset Management platform, roboadvisors etc.), they are ill-suited to a large part of the population. At a time when these tools are becoming ever more numerous, many people feel overwhelmed by the complexity of the financial world in which they live, and have difficulties making informed decisions: half of the population doesn’t have any financial goals defined (saving money, preparing its retirement, …). This underscores the need for a tool that helps people understand their own financial situation and recommends goals to achieve.The application is positioned as an interactive financial companion, transforming the crucial step of understanding one's financial situation. By merging advanced technologies with an intuitive user experience, Jared democratizes access to personalized financial information.Jared's innovative approach goes beyond raw data to analyze the financial psychology of each user. By integrating elements of behavioral finance and cognitive science, Jared deciphers the emotions and biases that influence financial decisions. The result is informed analysis and tailored recommendations that go beyond the numbers. Jared's content is tailored to the user's profile, assets and personality.1. Proactive financial education: Beyond simple notifications, Jared acts as an educational guide, providing contextual advice precisely when the user needs it. It transforms complex financial moments into learning opportunities, empowering users. 2. Simplicity and accessibility: By making complex financial information understandable and accessible, Jared democratizes financial management. Users benefit from a user-friendly interface that simplifies decision-making.3. Utilization of behavioral finance: We leverage insights from cognitive science not merely to acquaint ourselves with our users but to comprehensively understand them. We use unique psychometric tests specifically developed to identify hidden characteristics of user. This enables us to assess traits previously unexplored within the realm of finance, offering a deeper understanding of user behavior. 4. Unique competitive advantage in data: This competitive edge lies in our dynamic dataset. With an interactive nature, our dataset continually evolves, allowing us to refine the correlation between content and user profiles with each new data iteration. This agility empowers us to adapt our offerings in real-time, ensuring relevance and efficacy for our users.
  • Good Motors agency — Good Motors agency offers self-service motorcycle rentals near train stations and airports in France's most beautiful regions.
BNP Paribas VC Fund · Paris, Ile-de-France, France · 11 investments in the past 12 months
BNP Paribas provides banking, financing, investment, savings, and protection solutions. Their investment services include businesses that provide savings, investment, and protection services. They provide financing and investment services to retail customers, associations, businesses, and corporations.
Show more
Investment focus
  • Information Technology, Financial Services, Software
  • Debt Financing, Funding Round, Post-IPO Debt
  • France, United Kingdom, United States
Portfolio highlights
  • Grenergy — Grenergy specializes in research and development and sales of energy-saving power management chips. The company was founded in August 2016 and is headquartered in Nanjing, China.
  • Aprex Solutions — Aprex Solutions is a company that offers software and hardware solutions to transfer images and video into technical and scientific data.
  • Grenergy Renovables — Entwicklung von Photovoltaik und Speicher Projekten und Speicher Projekten mit Grenergy. Willkommen bei Grenergy
WiSEED VC Fund · Toulouse, Midi-Pyrenees, France
Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
Show more
Investment focus
  • Software, Manufacturing, Biotechnology
  • Seed, Funding Round, Equity Crowdfunding
  • France
Portfolio highlights
  • Leasi — Leasi delivers a forward-thinking rental and resource management system for companies that engage in internal or external distribution of machinery. This is achieved through an ecosystem that emphasizes the excessive use of data and datasharing, with a focus on user experience. Our goal is to create a simpler, more streamlined, and more efficientworkday for industry players by leveraging the power of data and collaboration within the ecosystem to ultimately reduce emissions, increase efficiency and enhance profitability.
  • Dianosic — Dianosic was founded in 2017 and develops innovative solutions in the field of ENT (Ear, Nose & Throat), a $50 billion, double digit growth, and still largely underserved market. Our startup operates right at the frontier between Medtech and Biotech, as we see tremendous opportunities for drug-device combinations in this specialty. The projectoriginates from the ENT Department from the University Hospital of Strasbourg, where unmet clinical needs have been identified. Our main focus areas are Chronic Rhinitis, Chronic Sinusitis and intranasal bleeding (Epistaxis). Noteworthy, Dianosic has a strong French and German footprint in R&D and manufacturing.Dianosic’s strategic goal is to establish new standards of care in Chronic Rhinitis and Chronic Sinusitis with its drug-eluting Active Resorbable Scaffold (ARIS). This drug-device combination ARIS platform, developed with world renowned resorbable polymers experts, has the potential to establish new treatment paradigms. Moreover, our ARIS platform creates immense opportunities to create other verticals, especially in the field of chronic migraine and facial pain.Beside this, Dianosic commercialize an Asymmetric Intranasal inflatable solution (CAVI-T) for the treatment of intranasal bleeding, a widespread condition in ENT that affects 10% of the population. This CE marked and FDA registered technology addresses a clear unmet need and demonstrated our ability not only to develop a differentiated technology in record time, but also to successfully transition from R&D to Sales. We are currently present in relevant markets in EU and paving the way to launch in the U.S. in the mid term. Noteworthy, since our main call point is the ENT, CAVI-T prepares the ground for our upcoming ARIS platform.
  • BiPER Therapeutics — BiPER Therapeutics : First-In-Class Therapeutics to Treat Cancer. Biotech company founded in 2021 to develop and commercialize novel therapeutics.
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
IRDI VC Fund · Toulouse, Midi-Pyrenees, France
IRDI Gestion is a private equity and venture capital institution.
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Funding Round, Series A, Series B
  • France
Portfolio highlights
  • REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
  • Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
  • Ascendance Flight Technologies — Sustainable flight solutions for today & tomorrow... because cleaner aviation can't wait. With Ascendance, Fly quieter, cleaner, further.
Angels Santé VC Fund · Puteaux, Ile-de-France, France
Angels Santé is a networking site for investors and companies in the health sector.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Seed, Funding Round, Angel
  • France, India, United States
Portfolio highlights
  • Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
  • Odimma — Empowering personalized immunotherapy to treat cancer
  • SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
Normandie Participations VC Fund · Colombelles, Basse-Normandie, France · 2 investments in the past 12 months
Normandie Participations is a venture capital fund that co-invests in companies based in Normandy. It invests through equity and quasi-equity in small and medium-sized enterprises. The firm was founded in 2016 and is based in Colombelles, France.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Seed, Series A
  • France
Portfolio highlights
  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • Loop Dee Science — Loop Dee Science is a DNA startup that makes molecular biology diagnostics. They develop and manufacture field genetic analysis kits for the detection of pathogen DNA and RNA. Their automatic field analysis device is a multi-spectral analysis device that provides local output and can also be connected via USB or Bluetooth.
  • Good Motors agency — Good Motors agency offers self-service motorcycle rentals near train stations and airports in France's most beautiful regions.
Paca Investissement VC Fund · Paris, Ile-de-France, France
Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.
Show more
Investment focus
  • Software, Internet, Manufacturing
  • Seed, Funding Round, Series A
  • France
Portfolio highlights
  • GANGZ — I found a great domain name for sale on Dan.com. Check it out!
  • SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
  • C4Diagnostics — C4Diagnostics developed a fast, reliable detection of microorganisms. Our Click-chemistry technology is at the core of our portfolio of diagnostic tests.
IRDI SORIDEC Gestion VC Fund · 6 investments in the past 12 months
IRDI SORIDEC Gestion
Show more
Investment focus
  • Biotechnology, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • France
Portfolio highlights
  • SCOP3 — SCOP3 is a platform that gives new life to professional equipment. SCOP3 was founded in 2021 and was headquartered in Montpellier, France.
  • TurnK — TurnK est le 1er Groupe de Service 100% No Code. Notre métier ? Concevoir, paramétrer et connecter entre eux vos outils métiers sans développement informatique. TurnK propose 4 services : #1 Web Design : Refonte de site vitrine & Ecommerce #2 Integration : Intégration et parametrage de votre CRM, ERP, outil de ticketing, marketing #3 AppBuilder: Création de votre outil métier personnalisé #4 Placement : Internalisation de compétence sur votre stack interne
  • IsyBuy — IsyBuy is a smartphone application that allows to find restaurants and bars that have your way, consult the menu, place order, and still pay your bill directly from your cell phone, with just one click. It's the fastest, easiest, and safest way to borrow and pay. They will never have to wait to be served by a waiter, let alone beg to receivethe account or the card machine.
Crédit Mutuel Innovation VC Fund · Paris, Ile-de-France, France · 3 investments in the past 12 months
Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Funding Round, Series A, Series B
  • France, United States, Canada
Portfolio highlights
  • UroMems — The device is developing an active implantable medical device based on the cutting edge technologyl in the field of embedded systems and micro-technologies for the development of its products.
  • Quandela — Quandela is an expert in the fabrication of performing devices for the research in quantum photonics and quantum information. They fabricate unique solid-state sources of quantum light. These sources bring a new revolution in quantum technologies based on light.The company's single-photon source device combines photonics and semiconductorquantum dots for quantum communication, computation and sensing and permits to collect the emitted single-photons with exceptional efficiency at high rates, enabling researchers to strongly reduce the charge noise decoherence and assist in the emission of identical photons with fidelity close to unity, an essential requirement for the development of the most advanced quantum applications.
  • Latitude — Venture Orbital Systems provides a tailor-made service for NanoSat & CubeSat operators.
CEA Investissement VC Fund · Paris, Ile-de-France, France
CEA Investissement (SA), founded (as CEA Valorisation) in 1999, is a subsidiary of the CEA, a major player in technological research, development and innovation. The central mission of CEA Valorisation is to create economic value based on technological innovations. To fulfill this mission, they have developed two main activities: Investmentin seed capital in innovative start-ups / start-ups active in the technology areas of CEA. The Licensing of advising companies and public laboratories of innovation in creative strategy development and marketing rights to patent or know-how belonging to the CEA, other research organizations or innovative companies. In addition, CEA contributes to the financing of national investment in seed technology (activity "Fund of Funds"), this activity is developed through particular Emertec management and funds managed by this company (FCPR Emertec 2 Emertec Energy and Environment), the FCPR managed by ACE Security Management SA, an investment company in seed priming Minatec SAS. Their areas of technological expertise are mainly micro-and nanotechnology, health technologies, the New Technologies for Information and Communication (NTIC), advanced materials and technologies for energy.
Show more
Investment focus
  • Biotechnology, Manufacturing, Software
  • Seed, Series A, Funding Round
  • France, Canada, United States
Portfolio highlights
  • ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .
  • Blue Capsule Technology — Blue Capsule Technology is a nuclear power company that specializes in the development of advanced innovative reactors to produce industrial-grade heat for industry.
  • ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .
UI Investissement VC Fund · Paris, Ile-de-France, France · 20 investments in the past 12 months
Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.
Show more
Investment focus
  • Manufacturing, Software, Health Care
  • Private Equity, Seed, Series A
  • France, Spain, Canada
Portfolio highlights
  • SURGAR — SURGAR provides a plug-and-play augmented reality software suite for computer-aided laparoscopic surgery.
  • Brenus Pharma — Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.
  • Quai des Notaires — Vente, succession, signez l'esprit tranquille. Sans rdv et gratuit ! Trouvez votre notaire en ligne.
Starquest Capital VC Fund · Paris, Ile-de-France, France
High Tech, Low Carbon: crafting tomorrow, today. We finance innovation to make tomorrow happen today. Starquest is a Montefiore Company.
Show more
Investment focus
  • Software, Manufacturing, Information Technology
  • Seed, Funding Round, Series A
  • France, Singapore, The Netherlands
Portfolio highlights
  • Cailabs — Cailabs is a French deep tech company, based in Rennes, which designs, produces and sells photonic solutions to fully exploit the industrial potential opened up by the shaping of light.Cailabs develops and produces a unique range of optical components based on its know-how and its patented technological innovations, in particular Multi-PlaneLight Conversion (MPLC).
  • Hello Watt — Hello Watt is a digital enthusiasts and developers who help you reduce your energy bills while improving your comfort.
  • Caeli Énergie — Caeli Énergie develops and manufactures next-generation air conditioners with great energy efficiency and a minimal carbon impact.
Octalfa VC Fund · Écully, Rhone-Alpes, France
Octalfa is a France-based venture capital firm that offers a range of financial services.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Funding Round, Seed, Series A
  • France
Portfolio highlights
  • Mathym — Mathym - a nanotechnology company dedicated to the development, manufacturing and commercialization of nanomaterials and nanodispersions.
  • Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
  • ORPHELIA Pharma — ORPHELIA Pharma is a French pharmaceutical company dedicated to the development and marketing of pediatric drugs for oncology and CNS diseases. ORPHELIA’s mission is to significantly improve essential medicines administered to children through the development of efficient, reliable and safe drugs with child-friendly formulations. We focus ondeveloping optimized formulations for the pediatric population of approved drugs as well as obtaining the approval for existing drugs in new pediatric orphan indications.
BNP Paribas Développement VC Fund · Paris, Ile-de-France, France · 10 investments in the past 12 months
BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Series A, Seed
  • France, Germany, The Netherlands
Portfolio highlights
  • Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
  • Brightflow — Brightflow operates as a medical device startup.
  • C12 Quantum Electronics — Explore C12's innovative quantum technology solutions using carbon nanotubes. Discover how our advancements in quantum computing are shaping the future of technology.
Truffle Capital VC Fund · Paris, Ile-de-France, France · 2 investments in the past 12 months
Business Builders, Truffle
Show more
Investment focus
  • Biotechnology, Financial Services, Health Care
  • Funding Round, Series A, Series B
  • France, United States, Belgium
Portfolio highlights
  • Obat — Obat is a saas solution provider that uses software for contractors and self-employed for invoicing.
  • Levenue — Levenue is a platform that helps recurring revenue businesses to get funded without dilution of shares
  • MoneyTrack — MoneyTrack is a global, decentralized blockchain platform for Directed Money.
Heartcore Capital VC Fund · Copenhagen, Hovedstaden, Denmark · 15 investments in the past 12 months
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more
Investment focus
  • Software, Artificial Intelligence, Machine Learning
  • Seed, Series A, Series B
  • Denmark, Germany, United States
Portfolio highlights
  • Skynopy — Connecting satellites. As a service
  • MAJORITY — MAJORITY is the first digital financial service dedicated to serving migrants worldwide. For $5 a month, MAJORITY members in the U.S. receive an FDIC-secured account, VISA® debit card, use of more than 55,000 ATMs across North America, remittance and international calling, native language advisors, and access to our network of community meet-upspaces, local discounts and events. With MAJORITY, there are never overdraft fees or minimum balance requirements. MAJORITY was started in Sweden by a diverse team of banking, fintech, payments, and telecom executives serving immigrant communities globally for the last 15 years. MAJORITY’s U.S. headquarters are in Houston, Texas.
  • Natural Cycles — Natural Cycles birth control is 93% effective with typical use and 98% effective with perfect use. Learn more about hormone-free birth control today.
Supernova Invest VC Fund · Paris, Ile-de-France, France · 8 investments in the past 12 months
we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Series A, Funding Round, Seed
  • France, Switzerland, United States
Portfolio highlights
  • UroMems — The device is developing an active implantable medical device based on the cutting edge technologyl in the field of embedded systems and micro-technologies for the development of its products.
  • Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
  • SEEDERAL Technologies — Seederal Technologies produces electric tractor.
Emertec VC Fund · Grenoble, Rhone-Alpes, France
EMERTEC’s experienced investment team has developed proven track record and has been able to develop close ties with major industrial players, many of them also being investors in their funds.These close ties are extremely valuable as to understand medium and long-term requirements of major order placers and high-level commercial opportunities.This brings visibility and confidence for entrepreneurs as well as for its investors.Their objective is to create value by turning ground-breaking technological innovations into commercial and financial successful companies.
Show more
Investment focus
  • Biotechnology, Energy, Software
  • Series A, Funding Round, Series B
  • France, Canada, United States
Portfolio highlights
  • Ynsect — We are the world leader in insect ingredient production for animals, people, and plants. Our goal? To make the way we eat more nutritious and sustainable.
  • eLichens — eLichens is a sensor tech company that takes sensor technology to the next level. Its mission is to empower people, companies, and government agencies to improve air quality, both indoor and outdoor.
  • Osmia — Osmia SAS provides crop pollination services to improve yield and quality of agricultural production. Osmia intervenes in the context of specific problems on entomophilous or anemophilic pollination. Methodological approach and experience enables the company to find relevant solutions. It offers pollination studies and services for pre-base, baseor multiplication seeds. It also offers simple and efficient pollination services for arboriculture and optimize the yields and the quality of the productions of fruit trees.Osmia SAS was founded on 2014 and is headquartered in France.
IXO Private Equity VC Fund · Toulouse, Midi-Pyrenees, France · 2 investments in the past 12 months
The private equity fund focused on adding high value.IXO Private Equity is a private equity management company recognized, approved and authorized by the Financial Market Authorities (AMF) operating under the number GP03018.IXO Private Equity is the most important independent regional private equity General Partner in France.The companymanages French General Private Equity Investment Funds (known in France as F.C.P.R.), Local Private Equity Investment Fund (known in France as F.I.P.), and Private Equity Investment Funds for Innovation (F.C.P.I.) to meet the equity needs for the best companies in Western and Southern France.
Show more
Investment focus
  • Health Care, Manufacturing, Biotechnology
  • Private Equity, Funding Round, Series A
  • France, United States, Canada
Portfolio highlights
  • F-Reg — F-Reg autonomous and intelligent hydraulic valves are designed to regulate and control flow patterns in sanitation networks. F-Reg sells solutions for regulating flow in networks (rainwater or wastewater) that rely on a patented valve that smooths out peaks in wet weather. The F-Reg device is self-contained and does not require power.
  • Indy — Indy offers end-to-end and advanced AI-powered accounting software. Indy is an accounting robot that aims to automate the accounting of freelancers and professionals. It is an accounting robot for the liberal professions. It automates the management of accounting, recovers bank entries to turn them into accounting lines, and sends tax returnsdirectly to an AGM.It was founded in 2016 as Georges by Côme Fouques, Pablo Larvor, Romain Koenig, and Adrien Plat to simplify independent accounting, which is certainly simple but repetitive and time-consuming.
  • Farmitoo — Farmitoo is an online purchase of farm equipment directly from manufacturers.
ACG Management VC Fund · Marseille, Provence-Alpes-Cote d'Azur, France
Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Funding Round, Seed, Series A
  • France, Madagascar
Portfolio highlights
  • Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
  • Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
  • My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.
Demeter VC Fund · Paris, Ile-de-France, France · 12 investments in the past 12 months
Demeter is a major player in venture capital and private equity for the energy and ecological transition. They invest from 500 K€ to 30 M€ to support companies at all stages of their development: innovative startups, high growth SMEs and infrastructure projects.
Show more
Investment focus
  • Manufacturing, Software, Renewable Energy
  • Funding Round, Seed, Series A
  • France, Germany, Slovenia
Portfolio highlights
  • Nutriearth — Nutriearth is a biotech firm that develops nutritional ingredients for human and animal health.
  • Pony — Instant city bike hire
  • Sirfull Technology — Solutions SIRFULL pour le soudage, l'inspection et la maintenance | Welding cloud logiciel soudage | Linspec Cloud logiciel inspection
AgFunder VC Fund · San Francisco, California, United States · 14 investments in the past 12 months
AgFunder invests in impactful companies that can positively transform the world's food system. Founded in 2013, AgFunder manages a portfolio of over 50 companies across four funds from offices in Silicon Valley and Singapore. Through its media platform AFN, it has built a global ecosystem of over 90,000 subscribers.
Show more
Investment focus
  • Agriculture, AgTech, Food and Beverage
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, India
Portfolio highlights
  • BioDefense — BioDefense presents Bioshield, which is made from food to protect your food, and it maximizes safety, freshness, and self-life for any fresh produce.
  • Bluemethane — We measure, capture and ultimately utilize methane from water to prevent its escape to the atmosphere, in turn creating a new bio fuel.
  • Wittaya Aqua — A better approach to aquaculture management
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 14 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
  • Formo — We're Formo, the future of dairy. Using micro fermentation, we create animal-free cheeses that humans love.
  • NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
XAnge VC Fund · Paris, Ile-de-France, France · 6 investments in the past 12 months
For 20 years, XAnge has been a key venture capital fund in Europe. With 70 startups in its portfolio, XAnge invests early in innovative tech companies.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Series A, Seed, Series B
  • France, Germany, Belgium
Portfolio highlights
  • Estuaire — Estuaire It seeks to strengthen the aviation sector by lessening its negative environmental effects. Their data firm is investigating all aspects of aviation pollution, such as CO2 emissions, NOx emissions, contrails, and aircraft production. Actionable indicators are provided to airlines, lessors, and carbon calculators to lessen the impact of airtravel.
  • Sirona Technologies — Pioneering direct air capture (DAC) technology with a focus on speed, scalability and a low capex design.
  • SamanTree Medical — SamanTree Medical has developed the Histolog Scanner, a confocal microscopy device intended for imaging the surface of excised human tissue specimens to visualize morphological microstructures. Easy-to-read images are available immediately, providing decision-making support at the point of care.
KREAXI VC Fund · Limonest, Rhone-Alpes, France · 5 investments in the past 12 months
Kreaxi is a management company specializing for over 30 years in investing in the capital of innovative and technological startups with high potential.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Seed, Funding Round, Series A
  • France, Italy, Switzerland
Portfolio highlights
  • QiOVA — QiOVA offers the services in the development of dynamic laser beam shaping solution. Their ambition is to develop a sustainable and mutually profitable business with its customers through unremitting innovation and cooperation.
  • B2eBike — B2ebike provides comprehensive electric bicycle fleet (VAE) solutions for businesses and communities. The best strategy to convert to a soft form of transportation.
  • Diamfab — Diamond semiconductor - DIAMFAB - Our project aims to manufacture a sustainable carbon-based diamond semiconductor !
Finovam Gestion VC Fund · Villeneuve, Provence-Alpes-Cote d'Azur, France · 3 investments in the past 12 months
Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.
Show more
Investment focus
  • Information Technology, Software, Medical Device
  • Seed, Funding Round, Series A
  • France, United States
Portfolio highlights
  • Nijta — Nijta provides a robust and secure speech anonymization solution to contact centers to access high-quality data for voice analytics.
  • Selvitys — Selvitys is a fully automated method for designing, delivering, and analyzing online surveys.
  • Osiris agriculture — Osiris desires to make agriculture more sustainable while also assisting farmers in living more peacefully. The business is working on a robot that will assist farmers in growing potatoes, sugar beets, and field crops. This four-wheeled robot will be able to automate and improve functions such as watering, fertilizing, weeding, and crop protection.
Aurinvest VC Fund · Paris, Ile-de-France, France
Aurinvest is a venture capital fund it is managed and primarily funded by more than fifty entrepreneurs and business leaders, alongside with institutional investors. The company's goal is to invest in high growth companies or ventures which are on the edge of an exciting journey. It accompanies the founders in successfully carrying out theirplan. With this purpose, each holding is coached by two experienced professionals who stay in close contact with companies' management and who interface with Aurinvest's network.
Show more
Investment focus
  • Software, Biotechnology, E-Commerce
  • Funding Round, Series B, Series A
  • France, United States, Belgium
Portfolio highlights
  • Famoco — Famoco provides an Enterprise Mobility Management (EMM) solution with a range of secure, remotely managed Android devices. Famoco offers...
  • PathoQuest — PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for biopharmaceuticals. Learn more.
  • Evercontact — Let Evercontact connect the dots in your life by turning your emails into an always-updated address book!
Casdin Capital VC Fund · New York, New York, United States · 5 investments in the past 12 months
Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. It manages a long-short equity fund and makes investments in early-stage to late-stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets undermanagement.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, France, China
Portfolio highlights
  • Idrx — IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies.
  • TMRW Life Sciences — TMRW helps patients and clinics safely store their eggs and embryos
  • BridgeBio Oncology Therapeutics — BridgeBio Oncology Therapeutics operates as a biopharmaceutical company.
Investors by industry
Investors by country
VC (Venture Capital) Funds in France by industry